Key result
Exogenous administration of nitro-oleic acid during ischaemia reduced infarct size by 46% and preserved left ventricular function compared with vehicle-treated mice.
Why the study?
The in vivo generation and therapeutic effects of nitrated fatty acids in myocardial ischaemia and reperfusion injury were not fully characterized.
Does exogenous administration of nitro-oleic acid reduce infarct size and preserve left ventricular function in a murine model of myocardial ischaemia and reperfusion?
Does exogenous administration of nitro-oleic acid reduce infarct size and preserve left ventricular function in a murine model of myocardial ischaemia and reperfusion?
Answers are grounded in this paper and cite their sources.
Exogenous administration of nitro-oleic acid protects against myocardial ischaemia/reperfusion injury in mice by reducing infarct size and preserving left ventricular function, partly via NFkappaB inhibition.
AIMS: Nitrated fatty acids (NO(2)-FA) have been identified as endogenous anti-inflammatory signalling mediators generated by oxidative inflammatory reactions. Herein the in vivo generation of nitro-oleic acid (OA-NO(2)) and nitro-linoleic acid (LNO(2)) was measured in a murine model of myocardial ischaemia and reperfusion (I/R) and the effect of exogenous administration of OA-NO(2) on I/R injury was evaluated. METHODS AND RESULTS: In C57/BL6 mice subjected to 30 min of coronary artery ligation, endogenous OA-NO(2) and LNO(2) formation was observed after 30 min of reperfusion, whereas no NO(2)-FA were detected in sham-operated mice and mice with myocardial infarction without reperfusion. Exogenous administration of 20 nmol/g body weight OA-NO(2) during the ischaemic episode induced profound protection against I/R injury with a 46% reduction in infarct size (normalized to area at risk) and a marked preservation of left ventricular function as assessed by transthoracic echocardiography, compared with vehicle-treated mice. Administration of OA-NO(2) inhibited activation of the p65 subunit of nuclear factor kappaB (NFkappaB) in I/R tissue. Experiments using the NFkappaB inhibitor pyrrolidinedithiocarbamate also support that protection lent by OA-NO(2) was in part mediated by inhibition of NFkappaB. OA-NO(2) inhibition of NFkappaB activation was accompanied by suppression of downstream intercellular adhesion molecule 1 and monocyte chemotactic protein 1 expression, neutrophil infiltration, and myocyte apoptosis. CONCLUSION: This study reveals the de novo generation of fatty acid nitration products in vivo and reveals the anti-inflammatory and potential therapeutic actions of OA-NO(2) in myocardial I/R injury.
No takes yet. Share an insight, caveat, or question.
Rudolph et al. (2009) studied myocardial ischaemia and reperfusion injury. nitro-oleic acid (OA-NO(2)) vs. vehicle was evaluated on infarct size (normalized to area at risk) (46% reduction). Exogenous administration of nitro-oleic acid during ischaemia reduced infarct size by 46% and preserved left ventricular function compared with vehicle-treated mice.
Synapse has enriched 10 related papers. Consider them for comparative context: